Genetic Signatures Limited (ASX:GSS)

Genetic Signatures Revenue

In the fiscal year ending June 30, 2026, Genetic Signatures had annual revenue of 19.33M AUD, down -2.14%. Genetic Signatures had revenue of 10.65M in the half year ending June 30, 2026, with 4.78% growth. That makes Genetic Signatures the 35,893rd largest company in the world by revenue and 633rd in Australia.

• Revenue: 19.33M
• Revenue Growth: -2.14%
• P/S Ratio: 0.88
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 17.04M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Asia Pacific 18.37M 89.2%
• EMEA 1.79M 8.7%
• Americas 433.00K 2.1%

Fiscal year ended Jun 30, 2026 See the full Genetic Signatures breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	19.33M	-422.00K	-2.14%
Jun 30, 2025	19.75M	5.99M	43.47%
Jun 30, 2024	13.77M	-7.75M	-36.00%
Jun 30, 2023	21.51M	-13.98M	-39.39%
Jun 30, 2022	35.50M	7.11M	25.06%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 26, 2026

Data Sources Report a data error